Artgen Biotech
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2 (NCT05270954) | Artgen Biotech | 2021-10-14 |
| Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF (NCT04824040) | Artgen Biotech | 2020-01-15 |
Track Artgen Biotech automatically
Every clearance here is in the API, with alerts when new ones post.